COMMUNIQUÉS West-GlobeNewswire

Voyager Therapeutics Announces First Patient Dosed in RESTORE-1, a Phase 2 Trial of VY-AADC Gene Therapy for the Treatment of Parkinson’s Disease
10/12/2018
CAMBRIDGE, Mass., Dec. 10, 2018 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (NASDAQ: VYGR), a clinical-stage gene therapy company focused on developing life-changing treatments for severe neurological diseases, today [...]
IMV Announces Updated Clinical Data Presentation for Lead Candidate DPX-Survivac’s Phase 1b/2 Immunotherapy Combination Trial at the ESMO Immuno-Oncology Congress 2018
10/12/2018
IMV to host an investor call on Thursday, December 13 at 8:30 a.m. ET to discuss the presentation DARTMOUTH, Nova Scotia, Dec. 10, 2018 (GLOBE NEWSWIRE) -- IMV Inc. (Nasdaq: IMV; TSX: IMV), a clinical stage immuno- [...]
Resonant Inc. Launches Filter IP Standard Library; Leading Power Amplifier Vendor Licenses First Fast-Track Quadplexer Solution from the Library
10/12/2018
Existing fabless customer expands relationship with license agreement GOLETA, Calif., Dec. 10, 2018 (GLOBE NEWSWIRE) -- Resonant Inc. (NASDAQ: RESN), a leader in transforming the way radio frequency, or RF, front-ends [...]
ProQR Receives € 4.7 million in Innovation Credit from Dutch Government for QR-110 for LCA10
10/12/2018
LEIDEN, Netherlands and CAMBRIDGE, Mass., Dec. 10, 2018 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR), a company dedicated to changing lives through the creation of transformative RNA medicines for the [...]
BrainsWay Selected to Participate in FDA Innovation Challenge: Devices to Prevent and Treat Opioid Use Disorder
10/12/2018
Company’s Deep Transcranial Magnetic Stimulation System is One of Only Eight Products Selected from Over 250 Applications for Potential Treatment of Opioid Use Disorder HACKENSACK, N.J., Dec. 10, 2018 (GLOBE NEWSWIRE [...]
Apricus Biosciences Reminds Shareholders to Vote Before the Special Meeting on December 14, 2018
10/12/2018
Seeking Shareholder Approval for Proposed Merger with Seelos Therapeutics, Inc. SAN DIEGO, Dec. 10, 2018 (GLOBE NEWSWIRE) -- Apricus Biosciences, Inc. (Nasdaq: APRI), a biopharmaceutical company advancing innovative [...]
Gritstone Oncology Advances Solid Tumor Bispecific Antibody Program into Lead Optimization Phase; Appoints Vice President of Antibody Therapeutics to Spearhead
10/12/2018
EMERYVILLE, Calif., Dec. 10, 2018 (GLOBE NEWSWIRE) -- Gritstone Oncology, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company developing the next generation of cancer immunotherapies to fight multiple cancer [...]
Anavex Life Sciences to Announce 2018 Fiscal Year End Financial Results on Wednesday, December 12, 2018
10/12/2018
Conference Call and Webcast To be Held Wednesday, December 12, 2018 at 4:30pm Eastern Time NEW YORK, Dec. 10, 2018 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical- [...]
Recro Pharma Announces Presentation of New Data Demonstrating IV Meloxicam’s Effect on Platelet Function at the 72nd PostGraduate Assembly in Anesthesiology
10/12/2018
MALVERN, Pa., Dec. 10, 2018 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (NASDAQ:REPH), a revenue generating specialty pharmaceutical company focused on therapeutics for the hospital and other acute care settings, today [...]
Optinose Announces First Patient Enrolled in Clinical Trial of XHANCE for Chronic Sinusitis
10/12/2018
Company also announces first patient enrolled in clinical trial of XHANCE for treatment of nasal polyps in pediatric patients YARDLEY, Pa., Dec. 10, 2018 (GLOBE NEWSWIRE) -- Optinose (NASDAQ:OPTN), a pharmaceutical [...]
Axsome Therapeutics Announces Positive Outcome of Interim Analysis of ADVANCE-1 Phase 2/3 Trial of AXS-05 in Alzheimer’s Disease Agitation
10/12/2018
IDMC recommends continuation of trial evaluating AXS-05 versus placebo in Alzheimer’s disease agitation IDMC recommends no further enrollment to single-agent bupropion arm NEW YORK, Dec. 10, 2018 (GLOBE NEWSWIRE) -- [...]
Trevena Promotes Robert T. Yoder to Senior Vice President and Chief Business Officer
10/12/2018
CHESTERBROOK, Pa., Dec. 10, 2018 (GLOBE NEWSWIRE) -- Trevena, Inc. (NASDAQ: TRVN), a biopharmaceutical company focused on the development and commercialization of new and innovative treatment options for patients in [...]
Menlo Therapeutics’ Successful Phase 2 Clinical Trial of Serlopitant Demonstrates Reduction of Pruritus Associated with Psoriasis
10/12/2018
Company to Conduct Conference Call and Webcast Today at 8:00am ET / 5:00am PT REDWOOD CITY, Calif., Dec. 10, 2018 (GLOBE NEWSWIRE) -- Menlo Therapeutics Inc. (NASDAQ: MNLO), a late-stage biopharmaceutical company [...]
Emerald Health Sees License Expansion of Pure Sunfarms Cannabis Production Operation to 687,000 Square Feet, one of Largest Production Capacities in Canada
10/12/2018
1.1 million square foot Pure Sunfarms facility steadily ramps capacity and production with industry-leading quality and yields in line with expectations VICTORIA, British Columbia, Dec. 10, 2018 (GLOBE NEWSWIRE) -- [...]
Axovant Reports Results of Exploratory Phase 2 Clinical Study of Nelotanserin in Lewy Body Dementia Patients Experiencing REM Sleep Behavior Disorder
10/12/2018
Primary efficacy endpoint assessed by sleep laboratory video assessment was not met Axovant is discontinuing clinical development of nelotanserin BASEL, Switzerland, Dec. 10, 2018 (GLOBE NEWSWIRE) -- Axovant Sciences ( [...]
Active Biotech provides updated information about the company's financial position
10/12/2018
PRESS RELEASE As announced in connection with the interim report for January-September 2018 Active Biotech has requested, from the bank that finances the company's property in Lund, that the agreed deadline for the [...]
LHC Group and LifePoint Health expand partnership with two acquisitions in North Carolina and Virginia
10/12/2018
LAFAYETTE, La., Dec. 10, 2018 (GLOBE NEWSWIRE) -- LHC Group (NASDAQ: LHCG) and LifePoint Health® today announced the continued expansion of their partnership. The companies have finalized two transactions to purchase [...]
Emblem launches new line of Oil Capsules
10/12/2018
Capsules are latest addition to the Company’s growing line of innovative medical cannabis products TORONTO, Dec. 10, 2018 (GLOBE NEWSWIRE) -- Emblem Corp. (TSXV: EMC, OTCQX: EMMBF) (“Emblem” or the “Company”), through [...]
BeiGene to Present Clinical Data on Anti-PD-1 Antibody Tislelizumab at the European Society for Medical Oncology Immuno-Oncology Congress
10/12/2018
CAMBRIDGE, Mass., and BEIJING, China, Dec. 10, 2018 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a commercial-stage biopharmaceutical company focused on developing and commercializing innovative [...]

Pages